Quantcast

Contract Research Organization WCCT Global Announces the Opening of a Newly Designated Asian Bridging Clinical Trials Unit

March 13, 2014

New Asian Bridging Clinical Research Unit has been opened by Contract Research Organization WCCT Global

COSTA MESA, Calif., March 13, 2014 /PRNewswire-iReach/ — WCCT Global, a full service CRO headquartered in Southern California announced today the opening of a new Asian Bridging clinical research site. This state of the art facility has been reconfigured to provide for 30 semi-private rooms to give each clinical trial volunteer a more comfortable experience for extended in-house stays. This dedicated clinical pharmacology unit is located in Orange County, California which is a central location enabling access to the many Asian populations that reside in the surrounding communities. WCCT Global has been conducting Asian bridging clinical trials for over 10 years and has conducted the largest Asian bridging clinical trial ever done in the United States. Over the past 5 years WCCT Global has conducted over 60 Asian Bridging studies and recruited over 1600 Asian volunteers during this 3-year period. Interestingly, over 20% of those trials have required extended overnight confinement (> 4 days) to the research center. Therefore, the availability of this “built-to-suit” extended stay facility will provide a more comfortable and attractive setting for research participants. WCCT Global reports that based upon volunteer exit survey results, safety and comfort are the 2 most important determinants for a volunteer’s decision to participate in “extended stay” clinical trials. Therefore, WCCT Global has also designed this new facility to accommodate every aspect of a volunteer’s research experience, from the meals they are provided to the utilization of their free-time in order to make the volunteers stay as enriched, safe and comfortable as possible.

(Photo: http://photos.prnewswire.com/prnh/20140313/MN82440)

WCCT Global’s Chief Operating Officer, Jon Rojas, stated “We decided to reconfigure this research center in response to our study participants’ survey responses. I think that we have created an extended-stay research center that will provide the safe and comfortable environment that our Asian bridging study volunteers have expressed the desire for. We wanted a unit that can make our volunteers as comfortable as possible while offering our clients the best ethno-bridging solution available.”

More About WCCT Global:

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, CLICK HERE.

Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE WCCT Global


Source: PR Newswire



comments powered by Disqus